M&A Deal Summary

Puracap Pharmaceutical Acquires Blu Pharmaceuticals

On March 23, 2016, Puracap Pharmaceutical acquired life science company Blu Pharmaceuticals

Acquisition Highlights
  • This is Puracap Pharmaceutical’s 2nd transaction in the Life Science sector.
  • This is Puracap Pharmaceutical’s 1st transaction in the United States.
  • This is Puracap Pharmaceutical’s 1st transaction in Kentucky.

M&A Deal Summary
Date 2016-03-23
Target Blu Pharmaceuticals
Sector Life Science
Buyer(s) Puracap Pharmaceutical
Deal Type Add-on Acquisition

Target

Blu Pharmaceuticals

Franklin, Kentucky, United States
Blu Pharmaceuticals LLC is a manufacturer and distributor of pharmaceutical products.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Puracap Pharmaceutical

South Plainfield, New Jersey, United States
Category Company
Sector Life Science
DESCRIPTION

Puracap Pharmaceutical LLC is a pharmaceutical company, that provides product development, manufacturing and distribution bringing, quality products & services.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 2 of 2
Type (Add-on Acquisition) 2 of 2
State (Kentucky) 1 of 1
Country (United States) 1 of 1
Year (2016) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-03-23 Blu Caribe

Dorado, Puerto Rico

Blu Caribe, Inc. is a manufacturer and distributor of quality generic pharmaceuticals products.

Buy -
Mergr

Product

Company

Legal